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Purpose: Positron emission tomography (PET) scanning is a widely used method of
proton therapy verification. In this study, a proton radiotherapy accuracy verification
process was developed by comparing predicted and measured PET data to verify the
correctness of PET prediction and was tested at the Shanghai Proton and Heavy Ion
Center.
Method: Irradiation was performed on a polymethyl methacrylate (PMMA) phantom.
There were two dose groups, to which 2 and 4Gy doses were delivered, and each dose
group had different designed dose depths ranging from 5 to 20 cm. The predicted PET
results were obtained using a PET prediction calculation module. The measured data
were collected with a PET/computed tomography device. The predicted and measured
PET data were normalized to similar PET amplitude values before comparison and were
compared using depth and lateral profiles for the position error. The error was evaluated
at the position corresponding to 50% of the maximum on the PET curves. The mean
and standard deviation were calculated based on the data sampled in the scoring area.
Gamma index analysis is also applied in the comparison.
Results: In the depth comparison, the 2 and 4Gy dose cases yielded similar mean depth
errors between 1 and −1mm, and the deviation was <2mm. In the lateral comparison,
the 2Gy cases had a mean lateral error around 1mm, and the 4Gy cases had a mean
lateral error <1mm, with a standard deviation <1mm for both the 2 and 4Gy cases. All
the cases have a gamma passing rate over 95%.
Conclusion: The comparison of these PMMA phantom cases revealed good agreement
between the predicted and measured PET data, with depth and lateral position errors
<2mm in total, considering the uncertainty. The comparison results demonstrate that
the PET predictions obtained in PMMA phantom tests for single proton beam therapy
verification are reliable and that the research can be extended to verification in human
body treatment with further investigation.
Keywords: proton therapy, positron emission tomography (PET), PMMA phantom, depth verification, lateral
verification
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INTRODUCTION
Proton therapy has already been confirmed to be an efficient
method of solid tumor treatment (1). A proton beam can deposit
most of its dose at the end of the beam range in the so-called
Bragg peak and can reduce the dose deposited along the beam
track in normal tissue. To achieve high accuracy, the Bragg
peak must be within the tumor region, and some method is
necessary to verify whether this requirement is met. A commonly
used method is positron emission tomography (PET) (2–4),
which can be employed to score the positron-emitting isotopes
generated by the incident protons. The PET device collects
positron annihilation signals from proton-activated isotopes such
as C-11 and O-15, and the signal is then reconstructed to form an
activity distribution image.
Although the generated positron-emitting isotopes can be
scored, the nuclear reaction process is different from the proton
energy deposition process. In addition, the depth dose range is
different from the isotope generation range, due to the cross-
section cut-off about 20–30 MeV (5) of the positron-emitting
isotope-generating channel (6). A proton with this energy can
typically still travel for a water equivalent depth of about 1 cm,
this is why the activity depth cannot directly reflect the dose
depth. One possible means of evaluating the dose delivery
depth is to compare measured and predicted PET images. The
predicted images can be generated by Monte Carlo simulation
(2, 7). By simulating the treatment plan, both the dose and
activity distributions can be scored. Monte Carlo simulation can
provide all the desired information, and the accuracy of the
results depends on the reference database and simulating primary
number. However, it takes a long time to obtain reliable results
via Monte Carlo simulation, and the simulated results strongly
depend on the cross-section data (8). Frey et al. (9) provided a
method of predicting PET activity distributions that takes much
less time than Monte Carlo prediction, and a prediction script
called PET-RV was developed based on this algorithm.
The objectives of this research were to verify the prediction
accuracy in phantom cases with plan series and to develop
a verification process. The results calculated using the PET-
RV module were compared with the PET scanning data from
the phantom irradiation experiment using a new statistical
comparison method to assess the accuracy of the calculation
results.
METHODS AND MATERIALS
Phantom Irradiation and PET Acquisition
In this experiment, we used polymethyl methacrylate (PMMA)
as the material of the phantom. The elemental composition
of PMMA is C5H8O2, its mass density is 1.19 g/cm
3, and
its stopping power relative to that of water is 1.156. This
material is widely used in particle therapy experiments (10–12).
The phantom was a transparent and homogeneous block with
dimensions of 30 cm × 20 cm × 20 cm. In this cubic phantom,
the clinical target volumes (CTVs) were designed as 5 cm× 5 cm
× 5 cm cubes with their centers along the central beam line, and
a depth series from 5 cm to 20 cm from the surface of the beam
entrance in 2.5 cm steps, as shown in Figure 1.
We designed an irradiation plan series for all CTVs at
different depths, with physical doses of 2 and 4Gy, since a dose
around 2Gy is commonly used for clinical proton treatment in
fractions. Following these experiments, we compared the PET-
RV predictions to the experimental measurements and analyzed
the differences between the distributions.
This experiment was conducted at Shanghai Proton and
Heavy Ion Center, where a proton beam is generated by a
linac-synchrotron combination similar to what is used at the
Heidelberg Ion Therapy Center (13). The proton beam energy
can be set between 48 and 221 MeV, corresponding to water
equivalent depths from 2 to 31 cm. The dose depth in the PMMA
phantom experiment was designed to be from 5 to 20 cm, a range
that is entirely covered by the available beam energies. The proton
particles were delivered spot by spot with pencil beam scanning
(PBS), from the lowest energy layer to the highest energy layer.
Depending on the dose that was required to be delivered in our
experimental cases, the delivery time varied from 1 to 3min.
The PET/computed tomography (CT) scanner was a Biograph
mCT (14) produced by Siemens, which has four rings of 192
blocks in total, each of which contains 13 × 13 lutetium-
oxyorthosilicate (LSO) crystals with dimensions of 4mm× 4mm
× 20mm. For this phantom experiment, the reconstructed PET
images had 200 × 200 pixels per slice, the image pixel size was
4mm × 4mm, and the slice thickness was 5mm. The pixels
in the reconstructed CT images had dimensions of 0.98mm ×
0.98mm, and again the slice thickness was 5mm. Offline PET
acquisition (4, 15) was used for data scoring. The cooling time
from the end of irradiation until the beginning of acquisition
was around 10min. Typically, a cooling time between 10 and
15min is suitable for most offline PET operation (12, 16),
especially when PET acquisition is performed on a patient.
The PET data acquisition took 30min, and the collected data
were reconstructed by conducting 2D ordered subset expectation
maximization (OSEM) (17) in Na-22 mode to ensure that no
decay time correction was applied. CT attenuation correction was
also applied to make the reconstructed results fit the predicted
results more closely.
PET Prediction Using PET-RV
All of our data calculations, comparison, and analysis were
performed using a RayStation Planning System (version 6.99).
To predict PET results using PET-RV, a complete data set for
treatment containing patient geometry information is necessary,
which is often presented as CT data with structural information
drawn by a doctor, as well, as an irradiation plan generated by a
treatment planning system (TPS).
A proton treatment plan is the primary requirement for
the script and contains information about the proton energy
layers, spot distribution on each layer, and details of each
spot. In addition, the spot scanning time course, including
the temporal information about proton delivery, cooling, and
acquisition duration, is necessary. Together with the activity
decay and washout time parameters in different tissues, the
temporal information is used to rescale the predicted PET values.
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FIGURE 1 | (A) 3D model of the phantom, CTVs, and beam direction. The center points of the CTVs are located along the beam line, with different distances to the
beam entrance surface. (B) PMMA phantom used in the experiments.
Furthermore, all possible reaction channels during irradiation
need to be considered in the calculations. Positron emitters such
as C-11, N-13, O-15, P-30, and K-38 have different half-lives.
In phantom cases, PMMA has three kinds of elements: C, O,
and H, and the corresponding channels are (cross section with
E>100 MeV): 16O(p,pn)15O (40mb), 16O(p,αpn)11C (20mb),
12C(p,pn)11C (40mb), 16O(p,α)13N (10mb). The cross section of
these channels is reported in ICRU-report 63 (5). These channels
should be enabled in the script.
The process through which PET-RV generates a predicted
activity distribution is similar to that of a treatment planning
system when finalizing a dose distribution based on a given plan.
A look-up PET data table is constructed in place of a dose data
table, and the corresponding data with the given particle energies,
directions, and other parameters are drawn. This reconstruction
process (9) with a look-up data table is much faster than Monte
Carlo simulation and yields highly accurate results.
Measured Data Smoothing and
Normalization
A co-registration between plan-CT and PET-CT is necessary
before the comparison, since the PET prediction calculation
is based on plan-CT and the measured PET data is acquired
under the geometry frame of PET-CT. In our experiment, the
CT co-registration is executed on the TPS platform, and the co-
registration is processed based onHU value. This phantomwith a
regular geometry shape is set to a patient coordinate and correctly
placed before CT scanning so the co-registration process will
need only translation and the rotation is not required. For the
patients’ case, co-registration technology is well developed for
clinical application, this will not be a problem in CT, as well as,
the PET image.
The acquired PET data did not have a smooth distribution,
Instead, there were numerous ripples in the curve due to the
background noise and attenuation correction based on the
CT Hounsfield unit value. Before the measured data could be
compared with the predicted data, it was necessary to smooth
these ripples.
Simple moving-average smoothing was applied to the
measured data. A new value was assigned to each voxel, which
was the mean of the values corresponding to five voxels in the
original data grid along the smooth processing axis: the current
voxel, two preceding voxels, and two subsequent voxels. The span
is always set to an odd number in moving-average smoothing,
and in this case, it was five voxels. This smoothing process was
applied to the measured data along the x, y, and z axes and
covered the entire data grid.
The measured results had a different scale than the PET-RV
prediction results. Our PET results were acquired by performing
offline PET, the PET/CT device was designed for nuclear
medicine data acquisition and image reconstruction. Thus, the
PET activity after irradiation of the phantom was much lower
than that of a patient injected with positron-emitting medicine.
Due to the low counting rate and noise effect, our measured PET
data could not provide real PET activity values in the phantom.
Furthermore, since the prediction script required some time-
related parameters to calibrate the calculation results with the
irradiation time course, this process could not be controlled
with complete accuracy, so we just considered the shapes of the
distributions rather than the actual PET values.
Before performing the comparison, it was necessary to
normalize the measured data to the prediction results. A factor
was multiplied to the measured data to rescale the value so that
measured results and the prediction results will have similar
amplitude, and this factor was determined based on the ratio
between the two sets of results. To find this ratio, it was necessary
to compare the PET values of both sets in a flat region, where
flat is defined as the activity distribution gradient being below a
certain threshold. First, the data points with PET values >50%
of the maximum were selected, since in the data grid, many
points had values of 0, forming a pseudo-flat region, but would
not have been appropriate to include in the comparison. Then,
to filter the points in the flat region, the gradients of all the
points were calculated by finding their slopes in the x, y, and
z directions, and for each point, if the three slopes were all less
than a predefined threshold, then the point was identified as a flat
point. This filtering process was conducted to generate a position
list containing all the points in the PET-RV prediction results that
were defined as flat.
Then, the filtering process was applied to the measurements.
Since the predicted and measured results had the same data
structure, it was not necessary to search all the points in the
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measured PET data grid. Instead, only the positions recorded in
the list from PET-RV filtering were searched, and it was checked
whether the gradient at each point was also less than the threshold
in themeasured data grid. Then, a new position list was generated
to record the points that were designated as flat in both the
measurements and PET-RV prediction results.
After identifying the common flat region, the multiplicative
factor could be generated by calculating the ratio between the
measured and predicted values for each point, compiling a ratio
list, and finding the mean value of this ratio list. The mean ratio
of this list was then applied to the measured data.
Depth Comparison of PET-RV Predictions
and Measurements
The activity distribution depth scoring line is set parallel to the
beam line. In this experiment, the plans were designed as doses
delivered uniformly to a cubic region of interest (ROI), so in the
transverse beam eye view (BEV), we set the scoring line uniformly
inside the transverse section of the ROI. Each CTV had a 5 cm
× 5 cm transverse section perpendicular to the beam line, which
was then set as the scoring section. As the data grid had voxel bins
with dimensions of 3mm × 3mm × 3mm, the interval along
the scoring line was also chosen to be 3mm, to avoid performing
unnecessary interpolation calculations, as shown in Figure 2.
For each scoring line inside the scoring section, two position-
PET curves were drawn, one each for the predicted andmeasured
PET data. Then, the depth difference on each line could be
FIGURE 2 | BEV of irradiated ROI (cyan). All of the scoring lines are
perpendicular to the transverse section and limited inside the cyan area. The
dimensions of the cyan area are 5 cm × 5 cm, and the scoring lines were
chosen to have an interval of 3mm.
evaluated and the statistical information about the global depth
error in each case could be obtained.
The most commonly used method of evaluating the range
error between two PET curves is to locate the position of the
half-maximum point R50 on the scoring curve at the distal fall-
off edge (2, 7, 10, 12, 16, 18). This method was also applied
in this study, as shown in Figure 3. First, the global maximum
value of the PET-RV prediction data was obtained, and half of
this maximum value was calculated and recorded as V50. Since
the measured results were already normalized to the predicted
results, the entire position locating process was based on this
V50 calculated from the predicted data. Then, for each position-
PET curve, the position on the curve with a corresponding PET
value equal to V50 was identified. Since both the entrance and
distal fall-off edges have positions with values equal to V50 in
a PET curve, it was also necessary to check that each point
was obtained when the PET value was decreasing rather than
increasing. After doing so, the point on the distal fall-off edge
with a PET value equal to V50 was defined as R50 of the curve.
Finally, after acquiring R50 for both the predicted and measured
PET curves, we calculated1R50 for each scoring line as the depth
error between the two PET curves along the scoring line:
1R50,depth = R50,pred − R50,meas
After calculating all of the depth errors, we obtained the mean
depth error in each irradiation case.
Lateral Comparison of PET-RV Predictions
and Measurements
Besides the depth, the lateral PET profiles needed to be checked
as well. Lateral profile scoring layers were set at different depths
from the beam entrance. As the dose and activity depth varied
among the different cases, the profile scoring layers were set at
depths ranging from 2.5 to 20 cm in 2.5 cm steps starting from
the entrance, with eight layers in total (Figure 4a). Since the
experiment cases have different dose depth, for example, in the
case of 10 cm dose depth, scoring layers at depth deeper than
10 cm cannot score valid data, thus only 4 layers with depth 2.5,
5.0, 7.5, and 10 cm will be employed for the lateral scoring in this
case. Different scoring layers will be employed in different cases.
The lateral scoring section was a square with two basis vectors
perpendicular to the beam direction vector. The section size
was 5 cm, and lateral scoring lines were set parallel to the basis
vectors, in intervals of 3mm, which was the same as the data
voxel size (Figure 4b). Along each scoring line, we obtained
the lateral distribution curves for the PET predictions and
measurements.
We similarly defined the positions of the left and right sides of
the curves by locating R50 (2). Unlike in the depth error analysis,
R50 could be located on either side of the lateral PET curves
(Figure 5). Similarly, we found half of the maximum value on the
predicted data curve and defined it as V50. Then, on each lateral
curve, we identified the positions of R50 on both the left and right
sides. To calculate the lateral error along each scoring line, 1R50
was calculated using
1R50,lateral = |R50,pred − R50,meas|
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FIGURE 3 | Sample depth score curve (left) and the definition of 1R50 on the scoring sample (right). V50 is defined by the predicted PET data.
FIGURE 4 | (a) Set scoring layer positions. The depth ranges from 2.5 cm (green) to 20 cm (yellow), in 2.5 cm steps, from right (entrance) to left. (b) Scoring lines in
each CTV section. To obtain the entire lateral curves, the scoring lines were extended to outside the CTV section.
This equation was applied to both the left and right sides. The
absolute value was taken to verify the relative position errors
rather than just compare the distribution widths. After collecting
all of the 1R50 values, we calculated the mean lateral position
error and deviation for each scoring layer.
Gamma Index Analysis
Gamma index analysis is also applied to the data comparison.
Similar to the method applied in dose verification (19), we can
also compare the data of prediction and measurement point by
point through the entire data grid. Gamma analysis method for
dose comparison evaluate both dose difference and distance-to-
agreement (DTA), and calculate a γ value for each data point of
the prediction data. If a point is γ <1, then this point is acceptable
with given criteria, otherwise, the prediction and measurement
distribution data at this point is not agreed. Detail of the γ
calculation can refer to other articles (19, 20) and will not be
mentioned here. Our point value difference and DTA tolerance
are set to 3% and 3mm, and the analyzing data grid has size of
36.90 cm × 23.10 cm × 21.60 cm with voxel size 3mm × 3mm
× 3mm. All the radiation plans have a gamma index analysis, the
prediction activity distributions are verified to the corresponding
measurement data, and the gamma passing rates of each plan are
calculated.
RESULTS
Global View of Plan Design and PET
Normalization
Our irradiation plans were designed for uniform dose
delivery to a cubic CTV. The dose distribution for
the 2Gy case with a depth of 15 cm is depicted in
Figure 6a.
The CTV for dose distribution was designed as a
cube with dimensions of 5 cm × 5 cm × 5 cm, and the
depth of the CTV center below the entrance was 15 cm
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FIGURE 5 | PET lateral scoring curves, where the lateral position errors between the PET-RV predictions and measurements were found on the left and right sides.
FIGURE 6 | Data distributions in the 2Gy case with a depth of 15 cm. (a) Dose
distribution, where the dose was designed for uniform distribution throughout
the CTV; (b) PET results predicted using PET-RV; (c) original measured PET
data; (d) measured PET data after smoothing and normalization. (b,d) have
similar ranges and values, which means that the measured data agreed better
with the predicted data after smoothing and normalization.
in this case. Thus, the distal dose fall-off edge depth
was actually near 17.5 cm, 2.5 cm deeper than the CTV
center.
The distal fall-off edge of the activity distribution had a depth
less than that of the dose distribution due to the channel cut-off.
For each phantom case, the calculations performed to make the
prediction took <30 s. As shown in Figures 6b–d, the predicted
PET data have a distribution range similar to that of themeasured
PET data but differ in absolute value, and after smoothing and
normalization, both the ranges and PET values are similar.
We drew a sample scoring line to illustrate how the smoothing
and normalization processes changed the measured PET curves.
In Figure 7, it is evident that the measured curve after smoothing
and normalization matches the predicted curve more closely,
especially on the distal fall-off edge.
PET-RV Prediction and Measurement
Depth Comparison
The depth errors between the PET-RV predictions and
measurements in the 2 and 4Gy cases are presented in Table 1
and Figure 8.
From Figure 8, it can be seen that the depth error 1R50
between the PET-RV predictions and measurements has a mean
value between 1 and −1mm in the PMMA phantom in each
case, considering that with the error bars, the absolute value
of 1R50 is <2mm in most cases. The 2 and 4Gy dose cases
have similar mean depth errors, but with a higher dose, more
protons are delivered, causing a high-intensity PET signal with
a better signal-to-noise ratio to be generated in the 4Gy cases.
Consequently, the error bars in the 4Gy cases are smaller than
those in the 2Gy cases. This finding is relatively acceptable
compared with those obtained in other research (21, 22) in which
patient data were employed, because a phantom is a uniform and
static material and will yield better results than the human body.
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FIGURE 7 | Sample depth scoring curves for predicted, measured, and smoothed and normalized PET data.
TABLE 1 | Depth error (PMMA) for different cases.
Depth/cm 5 7.5 10 12.5 15 17.5 20
2 Gy
1R50/mm 0.59 ± 0.75 0.31 ± 0.90 −0.09 ± 1.06 −0.55 ± 0.65 0.13 ± 1.44 −0.29 ± 0.85 −0.58 ± 1.44
4 Gy
1R50/mm 0.15 ± 0.97 −0.08 ± 0.63 −0.18 ± 0.71 −0.31 ± 0.59 0.05 ± 1.36 −0.46 ± 0.86 −0.26 ± 1.32
FIGURE 8 | PET activity depth error 1R50 for 2Gy and 4Gy cases with
different dose center depths.
Lateral Comparison of PET-RV Predictions
and Measurements
The lateral width error was scored on layers with different depths.
Since our plan series had different dose depths, the lateral scoring
layers were set only at the positions with valid PET data. We
scored the position errors between the PET-RV predictions and
measurements, and the results are presented in Figure 9.
It is evident that the mean lateral error is <1mm in most
cases, especially the 4Gy cases. The lateral position error in
the 4Gy cases is smaller than that in the 2Gy cases since,
as mentioned in section PET-RV Prediction and Measurement
Depth Comparison, a higher irradiation dose introduces lower
uncertainty.
Gamma Index Analysis Result
The gamma passing rates of each case are shown in Table 2.
All the cases have a passing rate over 95%, this rate meets
the clinical requirement of dose verification, while in PET data
gamma analysis the rate requirement maybe different to the dose
requirement. With the dose depth increasing, the passing rates
have a overall decreasing trend because the increasing depth will
create more voxels with non-zero activity values, with the effect
of noise signal, the passing rate is sure to reduce. Under the same
depth condition, the 4Gy cases always have a higher passing rate
than 2Gy cases, because the higher delivery dose will reduce the
effect of noise.
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FIGURE 9 | Lateral errors for the 2Gy (top) and 4Gy (bottom) cases with different depths.
TABLE 2 | The gamma passing rate of each radiation plan.
Depth/cm 5 7.5 10 12.5 15 17.5 20
2 Gy
Passing Rate/% 99.43 98.47 98.53 97.38 97.74 96.21 95.86
4 Gy
Passing Rate/% 99.54 99.26 99.30 97.98 98.59 96.70 95.94
DISCUSSION
Normalization Method and Threshold
As mentioned in section Measured Data Smoothing and
Normalization, neither the predicted nor measured PET data
present the actual PET activity values, and normalization
is necessary before comparison. Besides the flat region
normalization process introduced in section Measured Data
Smoothing and Normalization, there is another normalization
method that can be employed to obtain the ratio. In this method,
the sums of the predicted and measured data in the entire data
grid are calculated, and the ratio of these two sums is set as the
normalizing factor. This process is much simpler than flat region
normalization, but the errors of the depth comparison results
with sum normalization are larger than those with flat region
normalization. Typically, the mean depth error is >1mm when
sum normalization is applied. The reason for this difference
is that the sum of the data over the entire grid includes all of
the voxels in the data grid, which will introduce the effects of
noise in blank areas, while the flat region is filtered and selected
in the irradiation area, so the factor calculated by flat region
normalization yields better depth comparison results.
In flat region normalization, the gradient threshold for
the “flat” definition should be chosen with assessment. In
Frontiers in Oncology | www.frontiersin.org 8 November 2018 | Volume 8 | Article 523
Zhang et al. Proton Therapy Range Verification
the normalization process described in section Measured Data
Smoothing and Normalization, we first identified voxels with
PET values greater than half of the maximum and recorded
the total number of these voxels. We then searched both the
predicted and measured data grids and obtained the points in the
flat region. The number of flat points reflected how the threshold
worked, since with a different gradient threshold, the size of the
flat region would differ as well. The threshold was defined as how
much the PET value changed within 1mm, and the unit was 1%





Thus, we determined the threshold using THx = factor × TH1
and tried different factor values in the 2Gy dose, 15 cm dose
depth and 4Gy dose, 15 cm dose depth cases, which yielded the
results presented in Table 3.
As the factor increases, the threshold increases, as does the
applicable voxel number. The data in Table 3 demonstrate that
when the factor is 1.4, the number of flat voxels has a lower rate
of increase than it does with the other factor values. In addition,
when the factor was>2.0 or<0.5, the comparison did not exhibit
good fitness, so we set the normalizing gradient threshold factor
to 1.4 and applied the corresponding gradient threshold in each
case in the normalization process.
Definitions of PET Range and Position
In the depth and lateral verifications, the PET distal position was
defined as 50% of the maximum PET value on the distal falling
edge. In our data preprocessing, we attempted to define the PET
activity distribution ranges using the positions corresponding to
80, 50, and 20% of the maximum, which were recorded as R80,
R50, and R20, respectively. Figure 10 shows a sample activity
depth scoring curve. On the distal edge, R80 would be easily
affected by the ripples in the measured curve, even though the
smoothing process was already applied to the measured data.
R20 seems acceptable in the presented case, but it could also
be affected by the noise in the measured data (12). Since R20
was near the base line, the noise on the base line would have
affected the edge after normalization, so we did not use R20 for
verification.
There is also a range verification method that involves
shifting the curve to achieve good fitness between the predicted
and measured curves (12). However, in our phantom cases,
the measured data were normalized before performing the
comparison and information about the actual PET values may
have been lost. Even if we had forced a shift, the measured data
would have exhibited numerous ripples that would have affected
the comparison substantially and covered the useful information
on the distal edge. Therefore, we finally choose R50 to define the
PET range for both depth and lateral verification.
Time Course for in vivo Cases
For now, our experiment is executed on a homogenous solid
phantom with only one field, which means we do not need to
TABLE 3 | Number of flat points and ratio (number/total) for all of the voxels.
Trial case Total Factor
0.7 0.8 0.9 1.0 1.1 1.2 1.3 1.4 1.5 1.6








































FIGURE 10 | PET activity depth scoring sample along the beam direction (left) and the curve at the distal fall-off edge (right). The predicted and measured data show
good fitness at the distal fall-off edge after smoothing and normalization.
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consider for the washout yet, and the spots scanning time course
is also simplified with fixed particle delivery rate, spot motion
speed and layer shift time. This process shows a reasonable result
in this phantom because of the small radiation field and uniform
dose distribution. While in patient application, radiation field in
some treatment cases will be large and the spending time for one
field is even more than 15min. Under this condition, different
part of the generated positron isotope will not share the same
cooling time. One possible method to solve this problem is get
the spots delivery record from the accelerator, the calculation
process can apply different decay time for each spot generated
positron isotope then. Another method, if the spot record is hard
or not possible to access, then we need to construct different
spot scanning time course model for different kind of treatment
cases.
Washout parameter is another important factor for the
prediction if the calculation is applied in vivo. Mizuno (23)
provides a mathematical formulation for in vivo washout
process and Parodi (16, 24) provides parameters for the
formulation. In this phantom experiment the washout process
is not needed, only physical decay is applied in prediction
calculation. For in vivo applications, activity washout can
be calculated with different time parameters depend on
the HU value of the position. This work needs further
investigation.
CONCLUSION
In this study, we developed a process for comparing predicted
and measured PET images and verified the correctness of a PET
prediction module. It was necessary to smooth and normalize
the measured PET data for better fitness with the predicted data
before comparison. The depth comparison between the PET-RV
predictions and measurements yielded |1R50| of no more than
2mm with the error bars considered. The lateral position error
was also no more than 2mm. This comparison and verification
process was effective and demonstrated that the predictions could
fit the PET measurement range within an uncertainty of 2mm in
PMMA.
For the prediction process, the PBS time course was also
a parameter. Since irradiation history record analysis was not
implemented in the script, we used a fixed delivery time model
for the particle delivery. These fixed time parameters may not
have fit the actual plan execution processes perfectly, so the
predicted data distributions differed slightly from the measured
data. However, we performed normalization before comparing
the two types of data, so this difference did not affect the final
comparison. Another problem related to the time course is the
washout parameter. We employed a solid phantom, so this issue
was not problematic, but it will need to be dealt with for further
in vivo research.
Verification using a human-like model and patient body will
be performed in future investigations. This PET verification can
indicate whether the treatment plan is executed as expected by
comparing measured and predicted PET data. Thus, it allows
doctors to ascertain whether the delivery dose depth is too deep
and whether the organ at risk (OAR) is covered by the dose
distribution. This verification is applied on the first fraction of
treatment and physicians can tune the treatment plan before
delivering the remaining fractions.
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